Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A method for rapid preparation of pd-1ˉt cells by efficient gene editing and its application

A PD-1 and gene editing technology, applied in the field of biomedicine, can solve the problem of low plasmid transfection efficiency PD-1 gene editing efficiency, etc., and achieve the effect of improving gene editing efficiency, high efficiency and strong anti-tumor effect.

Active Publication Date: 2021-08-31
GUANGXI MEDICAL UNIVERSITY
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] However, although the existing CRISPR / Cas9 gene technology has been applied in many fields, it has also shown good results, but in terms of tumor treatment, especially knocking out the PD-1 gene on T cells is not in the public technology. Not involved, in addition, the existing CRISPR / Cas9 knockout PD-1 gene technology did not find the combined application of high penetration peptide small molecule TAT, so there are problems of low plasmid transfection efficiency and PD-1 gene editing efficiency

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A method for rapid preparation of pd-1ˉt cells by efficient gene editing and its application
  • A method for rapid preparation of pd-1ˉt cells by efficient gene editing and its application
  • A method for rapid preparation of pd-1ˉt cells by efficient gene editing and its application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0041] The present invention will be further described in detail below in conjunction with specific embodiments, and the given examples are only for clarifying the present invention, not for limiting the scope of the present invention.

[0042] The experimental methods in the following examples are conventional methods unless otherwise specified.

[0043] Materials, reagents, etc. used in the following examples. Unless otherwise specified, all can be obtained from commercial sources.

[0044] One, the material and reagent used in the embodiment:

[0045] Peripheral blood was collected from healthy volunteers, and the lymphocyte separation liquid was purchased from Tianjin Haoyang Biological Products Company.

[0046] Human liver cancer HepG2 cells (ATCC, product number HB-8065), the public can obtain this application material from the applicant, which is only used for repeating the experiment of the present invention, and cannot be used for other purposes.

[0047] 2. High-...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a method for obtaining PD-1-T cells, comprising the following steps: (1) obtaining human peripheral blood T lymphocytes; (2) plasmid transfection; (3) preparation of fusion cells; (4) PD Expansion of ‑1‑T tumor-specific T cells. The invention also discloses the application of the method for obtaining PD-1-T cells. The PD-1-T cells obtained by the method of the invention exclude negative inhibitory regulatory receptors and have a good anti-tumor effect. The adoptively treated cells effectively prolong the survival time of tumor-bearing mice and are suitable for promotion in the medical field.

Description

technical field [0001] The invention belongs to the field of biomedicine, and in particular relates to a method for rapidly preparing PD-1ˉT cells by efficient gene editing and its application. Background technique [0002] T cells in the body's immune system are the main component of lymphocytes. T lymphocytes are mainly used to resist foreign invaders and have various biological functions. It is the body's main "warrior" against disease invasion, infection and tumor formation. At present, the methods of tumor treatment are generally surgery, radiotherapy and chemotherapy. There are some problems in these methods, among which immune escape phenomenon will appear in adoptive therapy, which will affect the anti-tumor effect. [0003] PD-1 (programmed death1), that is, programmed death receptor 1, is a negative inhibitory regulatory receptor. When T cells are activated, the expression of PD-1 can be significantly increased. Through the combined effect with the ligand PD-L1, i...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N5/10C12N15/85A61K35/17A61P35/00
CPCA61K35/17C07K14/70521C12N5/0636C12N15/85C12N2510/00C12N2800/80C12N2810/10
Inventor 赵永祥周素芳李桂银
Owner GUANGXI MEDICAL UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com